Boostrix has become the first approved vaccine in the US to help protect infants younger than two months from pertussis (whooping cough). The US Food and Drug Administration (FDA) has approved Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed [Tdap]) for immunisation during the third trimester of pregnancy. Since 2010, the Centers […]